Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A time-to-treatment analysis in the medicine versus angiography in thrombolytic exclusion (MATE) trial.

Journal of interventional cardiology·2002
Same author

Role of prolonged intravenous heparin in unstable angina patients prior to coronary angioplasty.

Journal of interventional cardiology·2002
Same author

Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction.

European heart journal·2002
Same author

One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trial.

Arquivos brasileiros de cardiologia·2002
Same author

Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial.

Circulation·2001
Same author

Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial).

The American journal of cardiology·2001

相关实验视频

Updated: Jul 18, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

一项针对急性心肌梗塞的晚期再输疗法的随机试验. 心肌梗塞-6研究小组中的血栓溶解和血管整形.

E J Topol1, R M Califf, M Vandormael

  • 1Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195.

Circulation
|June 1, 1992
PubMed
概括

晚期的再输血治疗,包括血栓抑制剂或血管塑造术,可以在大多数患者中实现心脏病血管再通道. 虽然血栓溶解有助于防止左心室重塑,但对缩功能的长期益处需要在大型试验中进一步研究.

更多相关视频

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

相关实验视频

Last Updated: Jul 18, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

科学领域:

  • 心脏病学 心脏病学
  • 干预心脏病学 干预心脏病学
  • 急性冠状动脉综合征是什么

背景情况:

  • 实验和观察研究表明,晚期再注射有助于急性冠状动脉封闭后心肌的愈合.
  • 评估心脏病发作的血管通透性和治疗效益在晚入病患者是至关重要的.

研究的目的:

  • 评估在晚入病患者 (症状后6-24小时) 中实现心脏病发作血管通透性的可行性.
  • 确定包括血栓溶解和血管塑造在内的再注射治疗对心室功能和重塑的益处.

主要方法:

  • 一项双盲试验将197名患者随机分配给组织型等离子体激活剂或安慰剂.
  • 冠状动脉扫描评估了心脏病发作血管通透性;符合条件的患者随机分配到血管造形术或不进行血管造形术.
  • 在1个月和6个月后重新评估了心室功能和大小.

主要成果:

  • 血激活剂 (65%) 与安慰剂 (27%) 相比,心脏病发作血管通透率显著更高.
  • 与安慰剂相比,抗血栓治疗在6个月内阻止了左心室腔的扩张.
  • 血管整形显示初始再通道和功能改善,但没有晚期优势自发的再通道.

结论:

  • 在大多数进入晚期的患者中,通过血栓溶解或血管塑造可以实现心脏病血管再通道.
  • 血栓溶解干预有利地影响左心室重塑,但没有显示晚期缩功能益处.
  • 需要进行大规模试验,以证实晚期再输疗法降低死亡率的好处.